*1.Please list your first name, last name, and email:(Required.)

First name:

Last name:

Email:

*2.What is your specialty?(Required.)

*3.How many patients with thyroid cancer do you treat each week?(Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

*4.What is the most common actionable alteration in sporadic medullary thyroid cancer?(Required.)

RET mutation

BRAF mutation

RET fusion

NTRK fusion

*5.What would be the most appropriate treatment option for RET V804 M gatekeeper mutant thyroid cancer?(Required.)

Selpercatinib or pralsetinib

Vandetanib or pazopanib

Cabozantinib or sorafenib

Sunitinib or lenvatinib